BerGenBio Locks In Funding
BerGen Bio, the Norwegian biopharmaceutical research and development company, secured 7 million krone from local Sarsia Seed and Development funds to continue its leading research and development activities into new and original cancer treatments.
2 March 2011•2 mins read
